期刊
LEUKEMIA & LYMPHOMA
卷 49, 期 3, 页码 398-409出版社
TAYLOR & FRANCIS LTD
DOI: 10.1080/10428190701851364
关键词
lymphoma and Hodgkin disease; clinical results; chemotherapeutic approaches
Mantle cell lymphoma (MCL) is an aggressive lymphoma requiring intensive chemotherapy +/- autologous stem cell transplantation (SCT) to achieve optimal rates of progression-free survival. Here we review the treatment options for patients with newly-diagnosed or relapsed MCL and discuss recent advances in management, including the role of autologous and allogeneic SCT.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据